S

St. Francis Cancer Center | Greenville, SC

Research site
(Unclaimed)
Location
104 Innovation Drive, Greenville, South Carolina, United States of America

Site insights

Top conditions

Top treatments

AB122
GC4419
Azacitidine
MGCD516
Lintuzumab
APL-101
Venetoclax
Magrolimab

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

3 of 7 total trials

Adjuvant Chemotherapy in Patients With Intermediate or High Risk Stage I or Stage IIA Non-squamous Non-Small Cell Lung Cancer

The optimal treatment for Stage I or Stage IIA non-small cell lung cancer (NSCLC) remains controversial. Radiographic surveillance alone has been rec...

Enrolling
Non-Small Cell Lung Cancer
Other: 14-Gene Prognostic Assay
Other: Radiographic surveillance

To assess:* efficacy of APL-101 as monotherapy for the treatment of NSCLC harboring MET Exon 14 skipping mutations, NSCLC harboring MET amplification...

Enrolling
Glioblastoma Multiforme
Brain Tumor
Drug: APL-101 Oral Capsules

This is a Phase 1b open-label study to evaluate the safety and clinical activity of zimberelimab (AB122) in biomarker-selected participants with adva...

Active, not recruiting
Advanced Solid Tumors
Drug: zimberelimab

Trial sponsors

Actinium Pharmaceuticals logo
A
Arcus Biosciences logo
G
Gilead Sciences logo
Mirati Therapeutics logo
R

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems